1. Home
  2. HKPD vs AIXI Comparison

HKPD vs AIXI Comparison

Compare HKPD & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HKPD
  • AIXI
  • Stock Information
  • Founded
  • HKPD 2016
  • AIXI 2001
  • Country
  • HKPD Hong Kong
  • AIXI China
  • Employees
  • HKPD N/A
  • AIXI N/A
  • Industry
  • HKPD Other Pharmaceuticals
  • AIXI Computer Software: Prepackaged Software
  • Sector
  • HKPD Health Care
  • AIXI Technology
  • Exchange
  • HKPD Nasdaq
  • AIXI Nasdaq
  • Market Cap
  • HKPD 20.9M
  • AIXI 23.3M
  • IPO Year
  • HKPD 2025
  • AIXI 2023
  • Fundamental
  • Price
  • HKPD $1.18
  • AIXI $1.30
  • Analyst Decision
  • HKPD
  • AIXI
  • Analyst Count
  • HKPD 0
  • AIXI 0
  • Target Price
  • HKPD N/A
  • AIXI N/A
  • AVG Volume (30 Days)
  • HKPD 145.8K
  • AIXI 347.2K
  • Earning Date
  • HKPD 08-14-2025
  • AIXI 09-25-2025
  • Dividend Yield
  • HKPD N/A
  • AIXI N/A
  • EPS Growth
  • HKPD N/A
  • AIXI N/A
  • EPS
  • HKPD N/A
  • AIXI N/A
  • Revenue
  • HKPD $20,313,818.00
  • AIXI $70,314,315.00
  • Revenue This Year
  • HKPD N/A
  • AIXI $26.84
  • Revenue Next Year
  • HKPD N/A
  • AIXI N/A
  • P/E Ratio
  • HKPD N/A
  • AIXI N/A
  • Revenue Growth
  • HKPD 21.72
  • AIXI 18.84
  • 52 Week Low
  • HKPD $0.81
  • AIXI $1.08
  • 52 Week High
  • HKPD $3.79
  • AIXI $7.20
  • Technical
  • Relative Strength Index (RSI)
  • HKPD 43.49
  • AIXI 47.99
  • Support Level
  • HKPD $1.18
  • AIXI $1.10
  • Resistance Level
  • HKPD $1.32
  • AIXI $1.57
  • Average True Range (ATR)
  • HKPD 0.11
  • AIXI 0.12
  • MACD
  • HKPD -0.02
  • AIXI 0.03
  • Stochastic Oscillator
  • HKPD 2.27
  • AIXI 51.02

About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

Share on Social Networks: